OncoBytes Adaptive Learning Pathways™: Decoding Precision Diagnostics and Targeted Therapies in Glioma

Activity Overview

Welcome to this OncoByte Adaptive Learning Pathway!

Each OncoByte video consists of a 5-minute presentation delivered by our expert faculty on a key foundational topic in precision diagnostics and targeted therapies for glioma.

Prior to watching an OncoByte, you will be asked a question on the topic to assess your baseline knowledge and confidence. If you answer the question correctly and confidently, you will continue to the next topic. If you answer the question incorrectly or without high confidence, you will continue to the OncoByte video.

After proceeding through your customized learning pathway, you will be led to a panel discussion where our expert faculty will help you synthesize the latest information and data on precision diagnostics and targeted therapies in glioma, guiding your incorporation of these advances into everyday practice.

Target Audience

This educational program is primarily directed toward medical oncologists, advanced practice providers, nurses, and pharmacists who are involved in the management of patients with glioma.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Apply established diagnostic and classification criteria to accurately identify adult and pediatric gliomas
• Integrate genetic and molecular data to classify gliomas and create personalized treatment plans
• Evaluate recent clinical trial developments in targeted therapy, immunotherapy, and other innovative approaches for glioma care
• Identify strategies to incorporate targeted therapies, immunotherapies, and emerging treatments into pediatric glioma care

The staff of Physicians’ Education Resource^®, LLC have no relevant financial relationships with ineligible companies.

PER^® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This accredited continuing education activity was planned in accordance with the ACCME Standards for Integrity and Independence to ensure balance, objectivity, independence, and scientific rigor. Faculty were instructed to use generic names when possible and to base recommendations on the best available evidence. Proprietary product names may be referenced in clinical discussion for educational purposes only and do not imply endorsement.

This activity may include discussion of investigational, unapproved, or off‑label uses of drugs or devices. Learners are advised to consult prescribing information for products discussed. Content is provided for educational purposes only and is not a substitute for the independent clinical judgment of a health care professional. Learners are encouraged to critically evaluate the information presented and apply their own clinical judgment.

The views expressed are those of the individual faculty members and do not necessarily reflect the views of the accredited provider or any entity providing commercial support.

This activity may have used AI-assisted tools to support educational development. All content was reviewed and approved by qualified faculty or planners. The accredited provider retains full responsibility for accuracy, balance, and independence.